This article is a retraction of:
In Vivo Clearance of Apoptotic Debris From Tumor Xenografts Exposed to Chemically Modified Tetrac: Is There a Role for Thyroid Hormone Analogues in Efferocytosis?
A Retraction of the Original Research Article
In vivo clearance of apoptotic debris from tumor xenografts exposed to chemically modified tetrac: is there a role for thyroid hormone analogues in efferocytosis?
By Godugu K, Mousa SA, Glinsky GV, Lin H-Y and Davis PJ (2022). Front. Endocrinol. 13:745327. doi: 10.3389/fendo.2022.745327
Following publication, concerns were raised regarding the integrity of the images in the published figures. Image duplication concerns were identified in Figure 2 and 3.
The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted. The author(s) did not provide a response to this Retraction.
Citation: Frontiers Editorial Office (2024) Retraction: In vivo clearance of apoptotic debris from tumor xenografts exposed to chemically modified tetrac: is there a role for thyroid hormone analogues in efferocytosis? Front. Endocrinol. 15:1480220. doi: 10.3389/fendo.2024.1480220
Received: 13 August 2024; Accepted: 13 August 2024;
Published: 21 August 2024.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org